This study was initiated by the Direction de la Santé de la Famille et de Groupes Spécifiques (D10) and the Ministry of Public Health and carried out with technical and financial assistance from the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) and Integrated Health Project (PROSANI-Plus) implemented by Management Sciences for Health (MSH). The study stems from the many efforts by the Government and its partners to reduce maternal, infant, and, specifically, neonatal mortality.
Funding for the study, the report, and its dissemination was obtained from the Global Technical Reference Team for injectable antibiotics through the convener of the group, Save the Children.
